DaVita CFO to Participate in Investor Conference

Written by Emily J. Thompson, Senior Investment Analyst

Source: PRnewswire

Updated: Feb 24 2026

0mins

DVA+1.65%

Should l Buy DVA?

Source: PRnewswire

Investor Conference Participation: DaVita's CFO Joel Ackerman and VP of Investor Relations Nic Eliason will engage in a fireside chat at TD Cowen's 46th Annual Health Care Conference on March 2, 2026, highlighting the company's commitment to investor relations.
Global Patient Service: As of December 31, 2025, DaVita served approximately 295,000 patients across 3,242 outpatient dialysis centers, with 2,657 located in the U.S., demonstrating its extensive reach and impact in the global kidney care sector.
Clinical Quality Leadership: As a comprehensive kidney care provider, DaVita has led in clinical quality and innovation for over 25 years, significantly enhancing the quality of life for patients and showcasing its leadership in the healthcare industry.
Health Improvement Outcomes: DaVita has reduced hospitalizations and improved mortality rates, driving the kidney care community to adopt higher care standards, indicating its proactive role in enhancing patient health and healthcare quality.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy DVA?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on DVA

Wall Street analysts forecast DVA stock price to rise

5 Analyst Rating

1 Buy

3 Hold

1 Sell

Hold

Current: 152.270

Low

144.00

Averages

162.50

High

190.00

Current: 152.270

Low

144.00

Averages

162.50

High

190.00

Truist

Hold

maintain

$128 -> $158

2026-02-05

Reason

Truist

Price Target

$128 -> $158

AI Analysis

2026-02-05

maintain

Hold

Reason

Truist raised the firm's price target on DaVita to $158 from $128 and keeps a Hold rating on the shares. The firm is adjusting its model to reflect the company's Q4 earnings beat and above-consensus 2026 guide, the analyst tells investors in a research note.

TD Cowen

Hold

maintain

$133 -> $144

2026-02-04

Reason

TD Cowen

Price Target

$133 -> $144

2026-02-04

maintain

Hold

Reason

TD Cowen raised the firm's price target on DaVita to $144 from $133 and keeps a Hold rating on the shares. The firm updated its model following Q4 results.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DVA

Unlock Now

About DVA

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Berkshire Hathaway's Performance in Buffett's Last Quarter

22 hours agoMarketbeat

Warren Buffett's Departure: Warren Buffett stepped down as CEO of Berkshire Hathaway, marking the end of an era after over 60 years, with Greg Abel taking over leadership as the company reported its final earnings under Buffett's direction.
Financial Performance: Berkshire Hathaway's earnings fell significantly in 2025, with a nearly 25% drop in insurance investment income and a 6% decline in operating profit, despite a record cash reserve of $373.3 billion.
Stock Holdings and Acquisitions: Buffett's final moves included maintaining a strong portfolio with major holdings in Apple, American Express, and Bank of America, while also expanding positions in energy and media sectors.
Market Trends and Recommendations: Analysts are recommending five specific stocks for investors to consider, highlighting their potential for growth amidst broader market challenges, with a focus on sectors like energy and materials.

Three Key Sectors to Monitor While the S&P 500 Moves Sideways

2 days agoBarron's

Geopolitical Concerns: Ongoing geopolitical issues, including tensions related to Iran and international trade, are impacting market sentiment.
Tech Sector Pressures: The tech sector is facing challenges, particularly due to concerns surrounding artificial intelligence.
Investor Behavior: Instead of withdrawing from equities, investors are shifting their focus within the market.
Market Opportunities: This rotation in investment strategy is creating new pockets of opportunity for investors.

Top and Bottom Performing S&P 500 Stocks in February

5 days agoBarron's

Stock Market Performance: The S&P 500 remained just below the 7000 mark throughout February, indicating a period of stagnation in the stock market.
Economic Concerns: Ongoing tariff issues and worries about the impact of artificial intelligence on the economy are contributing to the uncertainty in the stock market as March approaches.